Kamada (KMDA) Stock Chart & Stock Price History $7.76 +0.01 (+0.06%) As of 01:34 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFDA EventsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Kamada Stock Price Performance The Kamada (KMDA) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 24.88%, with a year-to-date return of 27.34%. In the past month, the stock has increased 12.72%, reflecting recent market activity. As of the latest close, Kamada traded at $7.75 with a market cap of $445.66 million and volume of 59,663 shares. Five years ago, the stock traded at $8.50, representing a 8.76% decrease over that period. At the time, it had a market cap of $377.08 million and a volume of 198,700 shares. Receive KMDA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Kamada and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-1.21%1 Month Performance+12.72%3 Month Performance+23.49%Year-To-Date Performance+27.34%1 Year Performance+24.88%5 Year Performance-8.76% KMDA Stock Chart for Monday, July, 14, 2025 KMDA Chart by TradingView Kamada Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/11/2025$8.02$7.75-3.37%$8.01$7.7259,663 shs$445.66 million07/10/2025$7.85$8.02+2.17%$8.07$7.8199,793 shs$461.23 million07/09/2025$7.70$7.85+1.95%$7.89$7.7249,180 shs$451.45 million07/08/2025$7.71$7.70-0.13%$7.76$7.6238,463 shs$442.79 million07/07/2025$7.76$7.71-0.59%$7.92$7.7163,953 shs$443.40 million07/04/2025$7.76$7.76$7.88$7.7723,331 shs$446.01 million07/03/2025$7.74$7.76+0.21%$7.88$7.7723,331 shs$446.05 million07/02/2025$7.76$7.74-0.26%$7.83$7.6160,316 shs$445.13 million07/01/2025$7.75$7.76+0.13%$7.86$7.6750,251 shs$446.28 million06/30/2025$7.71$7.75+0.52%$7.82$7.7045,473 shs$445.70 million Get the Latest News and Ratings for KMDA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Kamada and its competitors with MarketBeat's FREE daily newsletter. 06/27/2025$7.90$7.71-2.41%$7.93$7.68106,214 shs$443.40 million06/26/2025$7.86$7.90+0.51%$7.92$7.8135,311 shs$454.29 million06/25/2025$7.95$7.86-1.13%$7.94$7.8059,648 shs$452.03 million06/24/2025$7.26$7.95+9.50%$8.20$7.49349,033 shs$457.20 million06/23/2025$7.20$7.26+0.83%$7.30$7.1975,623 shs$417.52 million06/20/2025$7.22$7.20-0.28%$7.30$7.1355,533 shs$414.07 million06/19/2025$7.22$7.22$7.30$7.1460,954 shs$415.22 million06/18/2025$7.14$7.22+1.12%$7.30$7.1460,954 shs$415.22 million06/17/2025$7.15$7.14-0.14%$7.25$7.1065,539 shs$410.59 million06/16/2025$6.88$7.15+3.92%$7.20$6.9990,056 shs$411.16 million06/13/2025$6.94$6.88-0.86%$6.99$6.78109,223 shs$395.63 million Related Companies Adaptive Biotechnologies Stock Price Chart Sarepta Therapeutics Stock Price Chart Tarsus Pharmaceuticals Stock Price Chart Immunocore Stock Price Chart Arcutis Biotherapeutics Stock Price Chart ARS Pharmaceuticals Stock Price Chart Schrodinger Stock Price Chart Ocular Therapeutix Stock Price Chart Vera Therapeutics Stock Price Chart Biohaven Stock Price Chart Receive KMDA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Kamada and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:KMDA) was last updated on 7/14/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredA new rule goes live in July — and the banks are quietly cashing inA major change is quietly going into effect this July — and Wall Street is already positioning for it. Big ...American Alternative | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredCentral Banks Are Hoarding Gold – Should You?The AI boom isn’t just transforming technology—it’s redefining global power, increasing government debt, and u...Lear Capital | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kamada Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kamada With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.